TY  - GEN
AU  - Gang,E J
AU  - Hsieh,Y-T
AU  - Pham,J
AU  - Zhao,Y
AU  - Nguyen,C
AU  - Huantes,S
AU  - Park,E
AU  - Naing,K
AU  - Klemm,L
AU  - Swaminathan,S
AU  - Conway,E M
AU  - Pelus,L M
AU  - Crispino,J
AU  - Mullighan,C G
AU  - McMillan,M
AU  - Müschen,M
AU  - Kahn,M
AU  - Kim,Y-M
TI  - Small-molecule inhibition of CBP/catenin interactions eliminates drug-resistant clones in acute lymphoblastic leukemia
SN  - 1476-5594
PY  - 2014///0610
KW  - Animals
KW  - Antineoplastic Agents
KW  - pharmacology
KW  - Asparaginase
KW  - Bridged Bicyclo Compounds, Heterocyclic
KW  - Cell Line, Tumor
KW  - Cell Proliferation
KW  - drug effects
KW  - Cell Survival
KW  - Dexamethasone
KW  - Down-Regulation
KW  - Drug Resistance, Neoplasm
KW  - Drug Synergism
KW  - Humans
KW  - Inhibitor of Apoptosis Proteins
KW  - genetics
KW  - Mice
KW  - Mice, Inbred NOD
KW  - Mice, SCID
KW  - Mutation
KW  - Peptide Fragments
KW  - antagonists & inhibitors
KW  - Precursor Cell Lymphoblastic Leukemia-Lymphoma
KW  - drug therapy
KW  - Pyrimidinones
KW  - Sialoglycoproteins
KW  - Survivin
KW  - Vincristine
KW  - Wnt Signaling Pathway
KW  - Xenograft Model Antitumor Assays
KW  - beta Catenin
KW  - metabolism
N1  - Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1038/onc.2013.169
ER  -